Centro de Investigaciones Clínicas Baigorria
Nos dedicamos a la mejora de la salud a través de la investigación clínica de alta calidad. Colaboramos con profesionales de la salud, investigadores y pacientes para avanzar en la medicina y ofrecer soluciones terapéuticas de vanguardia.San Jorge 204, S2152BOF Granadero Baigorria, Santa Fe, Argentina
Websitehttps://cicb.com.ar/
Select an option
I am a doctor
I am a sponsor
Specializations
Cardiologia
Diabetes
neumonologia
Hepatologia
Our team
Medical staff
MDJuan Manuel Dominguez
SubinvestigadorFranco Marino
NeumonologoRodolfo Navarrete
Maximilano Sicer
Juan Pablo Escalante
Legal and Administrative staff
Jefa de coordinadora de estudios clinicosVanesa wasinger
Coordinadora de estudiosElena Montequino
Coordinadora de estudios clinicos y nutricionistaVirginia Marzioni
Open studies
Arterial hypertension
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease - EASi-PROTKT™ - Boehringer IngelheimSee more
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1 - ATTAIN-HYPERTENSION - Eli Lilly and CompanySee more
Asthma
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma - Eli Lilly and CompanySee more
Elevated Lipoprotein A
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) - MOVE-Lp(a) - Eli Lilly and CompanySee more
Diabetes
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease - EASi-PROTKT™ - Boehringer IngelheimSee more
Cardiovascular disease
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease - EASi-PROTKT™ - Boehringer IngelheimSee more
Obesity
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1 - ATTAIN-HYPERTENSION - Eli Lilly and CompanySee more
Heart failure
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function - BalanceD-HF - AstraZenecaSee more
Renal disease
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function - BalanceD-HF - AstraZenecaSee more
